MBIO

MUSTANG BIO, INC.

Healthcare · Biotechnology

$185.80 sample

+0.39 (+0.21%) 1D

Market cap

$224.7B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-24

Alerts

8

Price$185.80 +3.02% 3M daily closessample

192.61172.72

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 24SECDEF 14A filed
Sep 21SEC8-K filed: material event
Sep 16INSInsider buy: Chief Executive Officer
Sep 07INSInsider sell: Director
Aug 27INSInsider sell: Director
Aug 21INSInsider buy: EVP, Operations
Aug 13INSInsider sell: Chief Financial Officer
Aug 05SEC10-Q filed

Sign up to see the real MBIO record →

Company facts

SEC EDGAR registration

Name: MUSTANG BIO, INC.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +37sample, -100 to +100
Reporting currency: USD

Who is positioning in MBIO

sample

Insiders: 6 insider transactions over 90 days, net selling, $55.2M
Congress: 2 members traded over 90 days
Institutions · 13F: 18 funds hold $4.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$5.4B +9.7% y/y

Q4 2024Q3 2026

Inventory$3.3B +9.2% y/y

Q4 2024Q3 2026

Accounts receivable$2.6B +18.3% y/y

Q4 2024Q3 2026

Total debt$6.5B +7.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $122.6B +2.6% 3M
Sample peer B: $147.4B +13.0% 3M
Sample peer C: $214.0B +6.8% 3M
Sample peer D: $186.9B -10.1% 3M
Sample peer E: $105.9B +8.7% 3M